Zdrowie i gospodarka · 10/06/2011
FDA Requests Public Comment on Proposed Collection of Information for In Vivo Radiopharmaceuticals
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to in vivo radiopharmaceuticals used for diagnosis and monitoring, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Health and Human ServicesOpen original release →